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ABSTRACT
The State of the Research: Meta-Analysis and Conceptual
Critique of Mild Traumatic Brain Injury
Ryan R. Green
Department of Psychology, BYU
Doctor of Philosophy
Researchers studying the long-term cognitive sequelae of mild traumatic brain injury (mTBI)
have produced disparate results. Some studies have shown little to no long-term cognitive effects
while others have shown that persistent cognitive sequelae continue to affect a subgroup of
patients. Meta-analysis has been used to try to integrate these contrasting results to foster a
coherent understanding of the cognitive outcomes following mTBI. However, previous metaanalyses of long-term cognitive sequelae have used studies from a period of mTBI research
where methodological rigor has been called into question (Carroll, Cassidy, Holm, Kraus, &
Coronado, 2004). Using studies from this period, meta-analysts found little to no effect for longterm cognitive sequelae after mTBI: g = 0.07, d = 0.12 (Binder, Rohling, & Larrabee, 1997), g =
0.11(Frencham, Fox, & Mayberry, 2005), and d = -0.07 (Rohling et al., 2011). The present metaanalysis was conducted to address problems with methodological rigor in the studies used in
these previous meta-analyses and address differences in meta-analytic methodology (Pertab,
James, & Bigler, 2009). Studies published between January 2003 and August 2010 were rated
using the 4-tiered American Academy Neurology (AAN) guidelines for methodological rigor to
ensure homogeneity and the methodological rigor of included studies. Seven studies were
identified that met criteria for a rating of I or II and five met criteria for the lower ratings of III or
IV. When studies of all ratings were combined, a significant effect of g = 0.45 was observed.
When only studies rated I and II were combined, a significant effect of g = 0.52 was observed
while a significant effect of g = 0.38 was observed when only studies rated III and IV were
combined. These effect sizes for long-term cognitive sequelae are much larger than those found
in previous meta-analyses. Based on these results, it is likely that methodological rigor and/or
heterogeneity amongst included studies can impact meta-analytic effect sizes associated with
long-term cognitive sequelae following mTBI. However, analyses did not show that more
rigorous studies (i.e., those rated I or II) had significantly higher effect sizes than less rigorous
studies (i.e., those rated III or IV), t(10) = .636, p = .845. This non-significant finding may be a
result of the analysis being underpowered given the small k. Significant effects for
neuropsychological domain were also observed and are reported. Additionally, a conceptual
critique of mTBI is made with recommendations for future development of the rating system that
Cappa, Conger, and Conger (2011) have put forth for objectively rating the methodological rigor
of neuropsychological studies. Concerns are addressed related to the mTBI literature in the areas
of mTBI definition, definition of cognitive impairment, problems with the constructs of postconcussion syndrome (PCS) and persistent post-concussion symptoms (PPCS), heterogeneity of
outcome measurement, and unaccounted for variables.
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The State of the Research: Meta-analysis and Conceptual
Critique of Mild Traumatic Brain Injury
Introduction
Traumatic brain injury (TBI) is a serious global health concern and accounts for a large
portion of traumatic deaths and disabilities. Conservative epidemiological studies indicate that
TBIs occur at an annual rate of about 2 million in the United States alone with associated
medical costs upwards of $17 billion (Center for Disease Control, 2003). Some studies place the
annual incidence much higher (Ryu, Feinstein, Colantonio, Streiner, & Dawson, 2009). The
majority of TBIs (70-90%) are classified as concussions or mild in severity 1 (Cassidy et al.,
2004), and mild traumatic brain injury (mTBI) has been termed the “signature injury” of our
current military engagements (Hoge et al., 2008; Rona, 2012).
Historically, many definitions of mTBI have been proffered (American Congress of
Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993; Bigler,
2008; Carroll, Cassidy, Holm, Kraus, & Coronado, 2004; Menon, Schwab, Wright, & Maas,
2010; & Ruff, Iverson, Barth, Bush, & Broshek, 2009). However, to date there is yet to be an
universally accepted definition of mTBI. There are many reasons why mTBI has eluded
definition. Despite some similarities in the neurologic effects of mTBI, the outcomes may vary
depending on the person and the type of injury involved. The biomechanics of mTBI are
different depending on the following: the angle of impact, if rotational forces are involved, and
which area of the brain was affected (Bigler, 2008). Given that various neurologic pathologies
are possible after a concussion, it stands that the cognitive and neurobehavioral sequelae that
may follow will also be quite varied thus making definition difficult. Additionally, since the
neurological effects of mTBI may not be observed when assessed with conventional
1

The terms concussion and mild TBI (mTBI) will be used interchangeably.
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neuroimaging techniques such as computed tomography (CT) and magnetic resonance imaging
(MRI), mTBI is often not considered to be severe enough to produce parenchymal abnormalities
that can then be used to define the phenomenon.
Interestingly, recent research has shown that the neurologic effects of mTBI can be
observed with more sophisticated but less available techniques such as in
magnetoencephalography (MEG), single photon emission computed tomography (SPECT),
positron emission tomography (PET), diffusion tensor imaging (DTI), and susceptibilityweighted imaging (SWI) (Ashwal et al., 2006, Bigler & Bazarian, 2010, Chen, Kareken,
Fastenau, Trexler, & Hutchins, 2003; Fox et al., 2012; Huang et al., 2009; Shenton et al., 2012).
Although many studies have been done using these techniques, many more well designed studies
are needed before these technologies will be able to more fully elucidate the potential
neurological complications following mTBI, which may in turn help disentangle some of the
definitional problems. Once this occurs, these technologies are more likely to be made clinically
available to diagnose mTBI. Additionally, metabolic processes following mTBI are also
beginning to be better understood which may help our understanding of the severity of brain
injury and prognosis of recovery. Potential biomarkers of mTBI have been observed in the
following neurochemicals: neurofilament light protein, glial fibrillary acidic protein,
phosphorylated tau, S100 proteins, and β-amyloid protein, to name a few (de Kruijk et al., 2002;
Nygren de Boussard et al., 2004). However, these methods are still being developed and
standardized and are of limited clinical availability.
Given the nascent stages of using advanced technologies and biomarkers to define mTBI
based on more objective, biological factors, mTBI has historically been defined as the result of
external force or rapid acceleration/deceleration forces that disrupt brain function. Mild traumatic
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brain injury is diagnosed using behavioral observations, history of the incident, and symptom
report. It is generally accepted that mTBI be demonstrated by the following criteria: Glasgow
Coma Scale (GCS) from 13 to 15, loss of consciousness (LOC) for less than 30 minutes, and
post traumatic amnesia (PTA) of less than 24 hours. An additional component of “alteration in
mental status such as being confused or disoriented” is often added to the definition as a
descriptive feature of the potential neurological disruption that is associated with mTBI
(American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest
Group, 1993; Carroll et al., 2004). Nevertheless, these definitional standards are not universally
accepted and researchers often vary in the definitions they use in their studies. The differences in
definitions used can potentially cause problems when comparing studies and trying to integrate
their findings. Indeed, given the heterogeneity of mTBI definitions used in research, Carroll and
coworkers (2004) stated that this definitional “problem has a negative impact on the
interpretation and comparison of findings on MTBI” (p. 113).
In light of the considerable concerns that concussions present to global health, and the
definitional problems associated with mTBI, several workgroups have been established in order
to better understand the prevention, diagnosis, treatment, and prognosis of concussion. These
groups include, but are not limited to: the American Congress of Rehabilitation Medicine Head
Injury Interdisciplinary Special Interest Group, the CDC Mild Traumatic Brain Injury Work
Group, the International Brain Research Foundation (IBRF), the Mild Traumatic Brain Injury
Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress
of Rehabilitation Medicine, and the World Health Organization (WHO) Collaborative Centre
Task Force on Mild Traumatic Brain Injury.
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An example of the work these types of groups have accomplished is important to further
establish the background and relevancy for the present study. Acknowledging the high rates of
mTBI, high associated costs, and potential for some level of disability in both industrialized and
non-industrialized countries, the World Health Organization (WHO) commissioned an extensive
literature review on mTBI. The WHO findings, based on the literature from 1980 to 2002,
demonstrated the variability of studies based on quality issues of research design and
methodological rigor (Carroll et al., 2004; Cassidy et al., 2004). Concurrent with the WHOsponsored mTBI studies, the International Conferences on Concussion in Sport (McCrory et al.,
2009) have addressed diagnostic, assessment, and outcome issues of sports related mTBIs. The
indisputable conclusion from both of these major consensus projects is that the vast majority of
those who sustain a mTBI recover quickly, successfully returning to baseline level of function
within hours, days or within approximately three months. Nevertheless, what remains
unresolved, and quite controversial, is whether some individuals with mTBI have cognitive
and/or neurobehavioral sequelae, directly related to neurological dysfunction caused by mTBI,
which persist beyond three months. Thus, one of the most pressing questions for mTBI
researchers centers on whether residual impairments persist beyond an acute stage of recovery,
how to predict residual impairment, and how to treat it if it occurs.
Answering these questions has been difficult due to methodological limitations in the
literature. For example, after performing the above mentioned comprehensive review of the
literature from 1980 to 2002, Carroll et al. (2004) concluded that the mTBI literature “is large
and of variable quality” (p. 113). Carroll and colleagues found that only 36% of the studies on
treatment, 32% of the studies on diagnosis, and 28% of the studies on prognosis were of
acceptable methodological quality. Cassidy (2010) summarized the Carroll et al. (2004) findings
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regarding the quality of research in mTBI and stated, “The scientific quality of studies on mTBI
was poor up to 2002” (p. e12). Additionally, Carroll and colleagues point out that numerous
other concerns plague mTBI research such as inconsistent definitions of mTBI and
heterogeneous measurement of mTBI which make a clear consensus of our understanding of the
cognitive sequelae of mTBI difficult to elucidate.
Moreover, Dikmen et al. (2009), after completing another systematic review of the
literature, concluded that “there is insufficient evidence to determine whether mild TBI is
associated with cognitive deficits 6 months or longer post-injury” (p. 430, emphasis added).
Similarly, Konrad and colleagues (2010) point out that, “Previous research on long-lasting
consequences of mTBI yielded ambiguous results. Some investigators reported no or only subtle
differences between control groups and patients several years after mTBI…By contrast, other
researchers found significant cognitive impairments even many years after mTBI. Thus, the
debate about long-term deficits of mTBI remains unresolved” (p. 9, emphasis added). Although
the majority of individuals who experience mTBI recover fully within hours to days to a couple
of months following the injury (Ponsford et al., 2000; Reitan & Wolfson, 1999; Voller et al.,
1999), it also appears that there may exist a subgroup of individuals, often referred to as the
“miserable minority,” who experience residual long-term deficits (Iverson, 2010; Miles et al.,
2008). It can be further seen that our understanding of the long-term sequelae of mTBI is unclear
given the various estimates of individuals who appear to suffer long-term sequelae which ranges
from zero to thirty-three percent (Binder, 1986; Binder, Rohling, & Larrabee, 1997; Frencham,
Fox, & Maybery, 2005; McCrea et al., 2003; Miles et al., 2008; Pertab et al., 2009).
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Review of Previous Meta-Analyses
Notwithstanding the difficulties and discrepancies in mTBI research, several metaanalyses have been conducted in order to attempt to synthesize our understanding of the potential
residual cognitive deficits associated with mTBI (Belanger, Curtiss, Demery, Lebowitz, &
Vanderploeg, 2005; Binder et al., 1997; Frencham et al., 2005; Pertab, James, & Bigler, 2009;
Rohling et al., 2011; Schretlen &Shapiro, 2003). Several of these meta-analyses will be reviewed
here. 2 In their frequently cited study, Binder et al. (1997) aggregated data from 8 studies with 11
samples and found an overall small effect of mTBI on post-acute cognitive impairment (d = 0.12,
p < .03). This effect was reduced and nonsignificant when using the more conservative g statistic
which corrects for sample size (g = 0.07). When domains of neuropsychological functioning
were evaluated, they found a small but significant effect for attention and concentration (d =
0.20, p <.006; g = 0.17, p < .02). From this effect, they reasoned that measures of attention may
be the most susceptible to chronic dysfunction after mTBI. Although Binder and colleagues
(1997) concluded that neuropsychological performance was reduced by less than 5% compared
to controls, that this reduction in performance may be accounted for by measurement error, and
that the average effect of mTBI on neuropsychological performance is undetectable, they
nevertheless indicated that their results may support one of two hypotheses: 1) there is an
association between mTBI and greater cognitive impairment in a small percentage of mTBI
patients (i.e., the “miserable minority”) or 2) there are small reductions in cognitive functioning
in a large percentage of mTBI patients. The fact that these authors indicated two possible
hypotheses regarding observed residual deficits in mTBI is important because their meta-analysis
is often cited as evidence that suggests there are no residual deficits following mTBI.
2

Meta-analysts will use different methods of coding whether they want the effect demonstrated as a negative or
positive number. This difference in methodology accounts for why some authors report results with positive or
negative numbers. In this paper, I use the original authors’ method of reporting.
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Frencham et al. (2005) conducted a follow-up to the Binder et al. (1997) meta-analysis.
Frencham and colleagues included studies published since the Binder et al. study up to 2003 and
extended the previous meta-analysis by including not only studies assessing mTBI in the postacute stage (i.e., post 3 months), but also studies assessing mTBI within 3 months of injury.
Seventeen studies met their inclusion criteria. These 17 studies yielded a significant overall
effect, g = 0.32, p <.001 when all stages post-injury were aggregated. When neuropsychological
domains were broken down and these data aggregated across all stages post-injury, speed of
processing measures yielded the largest significant effect, g = 0.47, p <.001 with working
memory/attention, memory, and executive functioning also yielding significant effects, g = 0.25,
g = 0.30, and g = 0.30, respectively. When studies reporting post-acute data were analyzed (k =
5), a nonsignificant effect size of g = 0.28 was reported. However, no power analyses were
reported in the study. When these five studies were pooled with Binder and colleagues’ postacute data, the effect size was considerably reduced, g = 0.11. Frencham et al. found a significant
moderating effect for time post-injury on neuropsychological performance across all stages postinjury that accounted for 22% of the variance in the effect of mTBI. They indicated that “the
effect size tended toward zero with increased time since injury” (p. 344). In the post-acute stage,
the relationship between time since injury and effect size failed to reach significance. Frencham
and colleagues concluded that this nonsignificant result likely supports the view that the majority
of recovery after mTBI occurs within the first 3 months and that subsequent improvement in
neuropsychological performance is of limited statistical and clinical significance. Like Binder et
al. (1995), Frencham et al. (2005) indicated that it is “possible that a sub-sample in the studies
summarized did have more severe cognitive deficits, and that the effect of their results has been
lost (in terms of statistical significance) by the pooling of data…[and] that a subgroup of
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approximately 15% may experience protracted cognitive recoveries” (p. 347). Again, this
statement is important to note because there is quite a strong movement in neuropsychology to
suggest that there is no long-term impairment in mTBI and if there is impairment, it is accounted
for by factors other than the brain injury (e.g., psychological factors, compensation seeking,
chronic pain, poor effort, premorbid conditions etc.).
Pertab and colleagues (2009) sought to clarify opposing views in the mTBI literature
regarding cognitive sequelae post three months. These authors re-analyzed the Binder et al.
(1997) and Frencham et al. (2005) data and argued that several constructs affect long-term mTBI
outcome including: 1) the mechanism of injury, 2) which diagnostic criteria are employed, 3)
which assessment tools are utilized, and 4) whether symptomatic groups are considered
separately. They concluded that, in the studies used in the Binder et al. and Frencham et al. metaanalyses, there was “significant statistical heterogeneity in the following areas: (a) the effect
sizes of neuropsychological measures employed in the post-acute phase (>3 months) and marked
qualitative heterogeneity, (b) in the criteria used to define mTBI and mTBI severity, and (c) in
the populations and mechanisms of injury from which the mTBI samples were selected” (p. 504).
Pertab et al. (2009) argued that because of the heterogeneity observed in the studies used in the
meta-analysis by Binder et al. (1997) and Frencham et al. (2005), it is likely that these metaanalyses have overlooked important information regarding the long-term outcomes following
mTBI and have, therefore, given an inaccurate assessment of these long-term outcomes.
Furthermore, these authors found that Verbal Paired Memory (g = -0.52), Coding Tasks (g = 0.33), and Digit Span (g = -0.33) remained statistically significant post three months when
compared to control groups. Pertab and colleagues pointed out that group statistics likely conceal
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a nested minority of patients who continue to suffer long-term cognitive sequelae following
mTBI.
Rohling and colleagues (2011) sought to clarify their own initial meta-analytic findings,
and conducted re-analyses of the Binder et al. (1997), Frencham et al. (2005), and Pertab et al.
(2009) meta-analyses with the purpose of analyzing epochs of time post injury and using a
random effects model; a model that had up to that point not been used in mTBI meta-analyses.
Rohling and colleagues found differences across epochs: 1) < 7 days post injury (d = -0.39), 2) 830 days post injury (d = -0.32), 3) 31-92 days post injury (d = -0.14), and 4) > 93 days post
injury (d = -0.07). These authors concluded that it is unlikely that a “highly impaired, but
undetected, subgroup of mTBI patients of any appreciable size” (p. 619) exists but that these
results may not generalize to individuals with complicated mTBI, history of multiple
concussions, and/or individuals with unequivocal neurological abnormalities such as hemiplegia.
The Continued Debate
The debate regarding mTBI meta-analyses has continued in the literature (Larrabee,
Binder, Rohling, & Ploetz, 2013; Rohling, Larrabee, & Millis, 2012). Ruff and Jamora (2009),
for example, point out many of the concerns with current meta-analyses and affirm many of the
conclusions from Pertab et al. (2009) by pointing out the following concerns: 1) different criteria
for diagnosing mTBI were used in meta-analysis source studies, 2) time intervals between injury
onset and assessment, and attrition rates varied considerably in source studies, 3) test batteries
used to assess cognitive abilities varied substantially in source studies, 4) control groups were
often poorly matched in source studies, 5) flawed sampling procedures in source studies, 6)
although critical to our understanding of mTBI, no attempt has been made to meta-analyze
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emotional and physical outcomes following mTBI, and 7) a separation between those in
litigation was not consistently reported in source studies.
Subsequent to this critique by Ruff and Jamora (2009) and in response to Pertab et al.
(2009), Rohling and colleagues (2012) conducted an empirical study based on the hypothetical
distributions presented by Pertab and coworkers to test whether a nested miserable minority of
mTBI survivors would actually be lost with group statistics. Rohling and colleagues point out
two important findings in their study. First, they state that their effect size (d = -1.60) from their
hypothetic sample of mTBI patients which did not consist of an impaired subgroup is not
equivalent to the effect size (d = -1.02) from a hypothetical sample that does comprise a
subgroup of impaired mTBI patients as asserted by Pertab et al. (2009). Second, they state that
both of these effect sizes estimates are much too large to genuinely represent the data found in
meta-analyses (i.e., previous meta-analyses have found effect sizes in the 0.07 to 0.12 range).
Bigler and colleagues (2013) then responded to Rohling et al. (2011) and reaffirmed their
initial findings regarding the limitations of previous meta-analyses published in Pertab et al.
(2009). Bigler and coworkers assert the following: 1) it is still possible that a nested minority
exist in previous meta-analyses and given that no power analyses were conducted in previous
meta-analyses there is no way to know whether these studies were well enough powered to
detect an effect if it were present, 2) the source studies used in previous meta-analyses have
methodological limitations (e.g., American Academy of Neurology [AAN] criteria differences),
3) problems with data transparency exist in previous meta-analyses (e.g., adding zeros in metaanalytic datasets when data was not given in source studies), 4) limitations in statistical and
methodological assumptions exist in previous meta-analyses, 5) limitations in research design in
the source studies of previous meta-analyses, 6) the possibility of a lack of sensitivity in
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neuropsychological assessment in source studies, and 7) the likelihood that previous metaanalyses perpetuate type II error by indicating that all mTBI patients get better.
Most recently, Larrabee, Binder, Rohling, and Ploetz (2013) published a rejoinder to
Bigler et al. (2013) again reaffirming their initial critique of Pertab et al. (2009). Among these
authors’ more substantial assertions are the following: 1) their statistical analyses (including Q,
tau2, and I2) preclude the possibility of a nested minority of mTBI patients who suffer long-term
cognitive sequelae, 2) that including patients with different etiologies of mTBI does not lead to
problems of heterogeneity, 3) that it is not problematic to code zeros for unreported statistical
data, and 4) that re-analysis of previous meta-analytic data did not show important differences
when AAN clinical practice guidelines were used to rank the methodological rigor of source
studies.
Despite these debates, previous meta-analyses (Belanger et al., 2005; Binder et al., 1997;
Frencham et al., 2005; Pertab et al., 2009; Rohling et al., 2011; Schretlen &Shapiro, 2003) have
nevertheless used source studies that were published during the era of mTBI research that the
WHO investigators (Carroll et al., 2004) originally pointed out is methodologically problematic.
These prior meta-analyses involved studies up to and inclusive of 2002, but for the most part
have not included studies published after 2002. Thus, debates about the merits and demerits of
previous meta-analyses are unlikely to be resolved using data from this time period; particularly
given that large scale, prospective, longitudinal studies that use an orthopedic-injury control
group have yet to be undertaken (see Bigler et al., 2013; Iverson, 2010; Larrabee et al., 2013;
Pertab, James, & Bigler, 2009; Rohling et al., 2011).
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The Current Meta-Analysis
The goal, therefore, of the current meta-analysis is to improve upon some of the
limitations recognized in previous meta-analyses. I intend to update the previous comprehensive
reviews regarding the state of the mTBI literature and meta-analyses by using studies from
August 2003 to January 2010, but apply greater front-end selection criteria in an attempt to
achieve greater uniformity and rigor in defining acceptable studies to include in the analyses
according to the WHO guidelines (Carroll et al., 2004; Cassidy, 2010). Cappa, Conger, and
Conger (2011) have shown the importance of establishing conclusions from meta-analyses
involving TBI based on the front-end selection process to better determine which studies to
include in the meta-analysis. Therefore, the guidelines set forth by the AAN in their clinical
practice guidelines (Edlund, Gronseth, So, & Franklin, 2004) which provide a four-point scale to
assess methodological rigor based on a priori conditions of the experimental design, and on
independence of data collection, analysis, and investigators, will be used in the current metaanalysis to determine methodological rigor and reduce heterogeneity among included studies
from 2003 to 2010 (see Tables 1, 2, 7, and 8 below). Edlund and coworkers state that the AAN
developed clinical practice guidelines “to assist its members in clinical decision makingparticularly in situations of controversy or variation in practice ” (2004, p. 6). Therefore, given
that long-term outcome following mTBI has been hotly debated and continues to be a
controversial topic, the process of rating methodological rigor of scientific studies set forth by
the AAN would be inherently helpful to improve homogeneity among articles and reduce the
amount of potential bias in articles selected for meta-analysis, and would therefore likely further
improve our understanding of long-term cognitive outcomes in mTBI.
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Regarding improving our understanding of potential bias in scientific studies, Edlund and
colleagues (2004) point out that bias and systematic error is the tendency to inaccurately measure
the variables of interest. They further indicate that it is not possible to directly study the amount
of “bias” in a study but that by using “well-established principles of good study design we can
estimate the risk of bias of a study” (p. 18). Regarding the 4-tiered AAN classification system,
these authors stated, “studies graded class I are judged to have a low risk of bias; studies graded
class II are judged to have moderate risk of bias; studies graded class III are judged to have a
moderate to high risk of bias; studies graded class IV are judged to have a very high risk of bias”
(p. 18). Indeed, as Borenstein, Hedges, Higgins, and Rothstein (2009) point out, “While a metaanalysis will yield a mathematically accurate synthesis of the studies included in the analysis, if
these studies are a biased sample of all relevant studies, then the mean effect computed by the
meta-analysis will reflect this bias” (p. 277). Thus, given the concerns related to potential bias in
scientific studies of mTBI, the AAN rating system will be used in the current meta-analysis to
determine and rank the methodological rigor of selected studies so an understanding of the
potential bias within each article can be estimated and the merits of the meta-analysis can be
better evaluated.
By nature, mTBI represents the mildest form of TBI. Therefore, the supposition with
regards to residual effects from a mild injury would be that any residual effects, if present, would
also likewise be mild. Accordingly, to detect subtle cognitive or neurobehavioral effects, studies
included in a meta-analysis of mTBI should only be those meeting a standard of methodological
rigor (e.g., the above mentioned AAN criteria) in order to reduce, as much as possible, any
experimental error or bias that may have entered into the data. Intuitively, this would imply those
with the greatest rigor in experimental design. Thus, by separating studies in the current meta-
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analysis based on methodological rigor, it may be possible to reduce the amount of error
associated with data collection/analysis (Cook & Campbell, 1979) and thereby minimize the
possibility that the mild effects of those who do experience residual deficits will be lost when
pooled with those who experience a good recovery. Moreover, when combining the effect sizes
from the most methodologically rigorous studies and combining the less methodologically
rigorous studies, comparisons between the levels of rigor can be performed to evaluate whether
there is a significant difference between the effect sizes produced by the studies based on their
ranking of rigor.
A further concern with regards to previous meta-analytic methodology (e.g., Binder et al.,
1997; Frencham et al., 2005) will be addressed in the current meta-analysis. This concern is with
the methodological handing of instances where non-significant data for neuropsychological tests
or domains were not provided by authors. Specifically, some authors of previous meta-analyses
have used a method which potentially minimizes the effect sizes associated with long-term
cognitive effects of mTBI by adding zeros to their data bases when authors of source studies did
not provide statistical information regarding non-significant results. More specifically, when the
authors of source studies found nonsignificant results, but did not give explicit statistical data,
those nonsignificant results were replaced by previous meta-analysts with an unspecified number
of zeros in their meta-analytic data sets. When this method has been used, authors did not make
explicit how many zeros were entered into the data sets and in which neuropsychological
domains. It is therefore difficult to objectively discern whether this methodology is appropriate.
In fact, it is arguably not a viable way to handle these instances as it will inevitably bias resultant
effect sizes toward zero. Thus, for the current and updated meta-analysis only studies with actual
data, which were presented in the articles, were used. In instances in which authors did not
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provide statistical information when nonsignificant results were found, authors were contacted
by email and asked to provide the additional statistical information. Several authors were
contacted and only two responded with data. However, these studies whose authors provided
data did not meet final inclusion criteria and therefore the provided data were not used in the
current data set.
In summary, three primary concerns are being addressed by the current meta-analysis: 1)
conducting an updated review of studies published from 2003 to 2010 to ensure the most recent
and rigorous studies are being incorporated, 2) using AAN criteria for rating methodological
rigor of studies to limit potential bias and increase homogeneity, and 3) using a methodology that
does not add zeros to the data sets when statistical information is not available. Addressing these
concerns, I hypothesize that the current meta-analysis will demonstrate an overall effect size
significantly greater than zero indicating poorer cognitive performance being associated with
individuals who have experienced mTBI compared to controls in studies from 2003 to 2010.
Additionally, given that systematic bias based on potential methodological problems is a concern
for researchers and meta-analysts, this concern will be directly addressed by comparing the effect
sizes of studies that received higher methodological rigor ratings (e.g., I and II) to the effect sizes
of studies that received a lower methodological rigor rating (e.g., III and IV). It is hypothesized,
therefore, that the cognitive impairment effect size in the mTBI groups in studies receiving the
higher methodological rigor rating of I or II will be larger than the cognitive impairment effect
size in the mTBI groups in studies receiving a lower ranking of III or IV. By testing this second
hypothesis, I will be better able to determine whether the AAN clinical practice guidelines
rankings are good indicators of the potential systematic error associated with studies that vary in
methodological rigor. Accordingly, the hypotheses of the current study are:
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1) Cognitive performance of mTBI group < Cognitive performance of control group
2) Effect size in studies receiving an AAN rating of I and II > Effect size in studies
receiving an AAN rating of III or IV.
Methods
Search Procedures
An online literature search was conducted through the PubMed database using the search
term “mild traumatic brain injury.” Search dates were limited to those articles published
between January 2003 and August 2010. This resulted in 1,631 articles being identified.
As some of the articles in the original search were not relevant, the authors narrowed selection
by reviewing titles and abstracts for the terms: mild traumatic brain injury, mild head injury,
minor head injury, concussion, postconcussive syndrome, mild closed head injury, Glasgow
Coma Scale/Score, brain trauma, and post traumatic amnesia (see Figure 1).
A similar search was conducted using the online database PsychINFO in order to ensure a
more comprehensive search. The same procedures as outlined above were used. This search
yielded 477 results. No studies were found in addition to the search results of the PubMed
search.
Again, a similar search was conducted using the online database PsychEXTRA in order
to search for unpublished studies (e.g., theses and dissertations) and directly assess publication
bias. It has been pointed out that studies which are not published may be systematically different
than published studies (Vevea & Woods, 2005). No additional studies were found.
To further assure no articles were missed, seven major journals (Archives of Clinical
Neuropsychology, Applied Neuropsychology, Brain Injury, Journal of Clinical and Experimental
Neuropsychology, Journal of the International Neuropsychological Society, Neuropsychology,
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and The Clinical Neuropsychologist) which publish in the area of neuropsychology and mTBI
outcome were then reviewed using the methods described above to determine if any articles had
been overlooked in the original online database searches. No new articles were identified.
Inclusion Criteria
To be included in the present study, articles had to meet several criteria in order to
establish further homogeneity and permit calculation of effect sizes for cognitive domains of
functioning. 1) Studies published or unpublished from January 2003 to August 2010 had to
include mTBI patients and a non-brain injured control group(s) in their comparisons. If authors
did not separate severity of TBI in their analyses even if mTBI subjects were included, the study
was excluded. 2) Patients had to be evaluated using validated clinical measures in the post-acute
stage of recovery (i.e., post 3 months) and have experienced only one mTBI. 3) Participants had
to be 16 years old or over (given that this the age at which the Wechsler Adult Intelligence Scale
–IV begins). 4) Participants were included in studies based on history of TBI by presenting to a
hospital where mTBI was diagnosed or medical records were available to substantiate the mTBI
history. 5) Studies needed enough information to calculate effect sizes. In instances where
studies did not have information to calculate effect sizes, but met all other criteria, the authors
were contacted in order to procure the necessary data to calculate effect sizes. If authors
responded with the needed statistical information, the data was included. 6) Studies must have
been written in English or an English translation must have been available. 7) Articles not
relevant to the current study (e.g., review articles and animal models) were excluded. 8) Studies
which included participants with previous psychiatric conditions were also excluded given that
history of psychiatric condition can account for a large proportion of the variance of individuals
with persistent post concussion symptoms (Luis, Vanderploeg, & Curtiss, 2003). 9) For
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longitudinal studies (e.g., Heitger et al., 2006), data was used from the three-month time point
unless the range of time post mTBI indicated the possibility of individuals not being three
months post TBI in which case we used the six-month follow-up data. Figure 1 below details the
inclusion/exclusion process.
Rating of Methodological Rigor
As previously stated, the AAN ratings were used to objectively determine methodological
rigor. Each article from the 2003 to 2010 timeframe was ranked according to the 4-tier AAN
clinical practice guideline criteria (See Edlund et al., 2004 and Tables 2, 7, and 8 below for
details). The attempt was made to follow the guidelines as explicitly as possible.
Three independent doctoral students rated studies based on the AAN clinical practice guideline
criteria (Edlund et al., 2004). Each rater was responsible for rating two-thirds of the articles.
Table 1 illustrates the overlap among the raters and the articles which they were individually
responsible for rating. This method was used to ensure that each article was rated independently
by at least two different raters. Raters used separate spread sheets to rate the rigor of the articles
based on the six domains assessed by the AAN ratings (e.g., comparison group, study design,
patient spectrum, reference standard, completeness, and masking). Table 2 below briefly outlines
the criteria used to determine the overall rating of an article (see Edlund et al., 2004 for further
details). Once the six domains were assessed, a final rating was given for the article based on the
lowest rating for each of the six domains. When all articles had been rated by all three raters, the
raters then compared their ratings of the studies assigned to them. If discrepancies were observed
between ratings, the original article was reviewed by both raters together to determine why the
discrepancy occurred. (The original methodology for the study indicated that when discrepancies
between raters were observed and difficult to rectify, the original article would be reviewed by
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three independent neuropsychologists [two of which are board certified] to determine the most
accurate rating. However, this was not necessary as discrepancies were easily rectified.)
Interrater reliability was not calculated because it was determined that an accurate rating was
more important than interrater reliability. All ranked studies were examined for potential
moderator variables and data that could be used to calculate effect sizes. It was necessary to
contact two authors whose studies were given a rating of II (Miles et al., 2008; Ge et al., 2009) as
Figure 1
Flow Chart of Inclusion/Exclusion Process
Initial PubMed
search yielded
1,631 results

E.g., Animal model,
child, review, not
English, etc.

Narrowed to 273
based on title and
abstract

Twenty studies
initially ranked I
or II

Twenty-two studies
not rated and flagged
for further analysis

Seven studies rated I or II
met final inclusion criteria

E.g., Mixed severity
of TBI, no cognitive
data, acute mTBI,
etc.
Fifty-three
studies initially
ranked III or IV

Five studies rated III or
IV met final inclusion
criteria

Did not meet final
analysis of AAN
criteria and study
inclusion criteria.
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Table 1
Overlap Among Raters
AAN
Rater
1
2
3

First
Third of
1,631
Articles
X
X

Second
Third of
1,631
Articles
X
X

Third Third
of 1,631
Articles
X
X

Table 2
AAN Guidelines
Rating of Diagnostic Article
Class I: Evidence provided by a prospective study in a
broad spectrum of persons with the suspected condition,
using a reference (gold) standard for case definition, where
test is applied in a blinded evaluation, and enabling the
assessment of appropriate tests of diagnostic accuracy. All
patients undergoing the diagnostic test have the presence
or absence of the disease determined.

Class II: Evidence provided by a prospective study of a
narrow spectrum of persons with the suspected condition,
or a well designed retrospective study of a broad spectrum
of persons with an established condition (by “gold
standard”) compared to a broad spectrum of controls,
where test is applied in a blinded evaluation, and enabling
the assessment of appropriate tests of diagnostic accuracy.
Class III: Evidence provided by a retrospective study
where either persons with the established condition or
controls are of a narrow spectrum, and where the reference
standard, if not objective, is applied by someone other than
the person that performed the test
Class IV: Any design where test is not applied in an
independent evaluation OR evidence provided by expert
opinion alone or in descriptive case series without controls.

Rating of Prognostic Article
Class I: Evidence provided by a prospective study of a
broad spectrum of persons who may be at risk for
developing the outcome (e.g. target disease, work
status). The study measures the predictive ability using
an independent gold standard for case definition. The
predictor is measured in an evaluation that is masked to
clinical presentation and, the outcome is measured in an
evaluation that is masked to the presence of the
predictor. All patients have the predictor and outcome
variables measured.
Class II: Evidence provided by a prospective study of a
narrow spectrum of persons at risk for having the
condition, or by a retrospective study of a broad
spectrum of persons with the condition compared to a
broad spectrum of controls. The study measures the
prognostic accuracy of the risk factor using an
acceptable independent gold standard for case definition.
The risk factor is measured in an evaluation that is
masked to the outcome.
Class III: Evidence provided by a retrospective study
where either the persons with the condition or the
controls are of a narrow spectrum. The study measures
the predictive ability using an acceptable independent
gold standard for case definition. The outcome, if not
objective, is determined by someone other than the
person who measured the predictor.
Class IV: Any design where the predictor is not applied
in an independent evaluation OR evidence provided by
expert opinion or case series without controls.
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it was unclear whether the samples used in these two studies overlapped. We were informed by
the lead contact in those studies that the samples did not overlap and both articles were included.
Additionally, when data to calculate effect sizes was not presented, attempts were made to
contact authors for additional data and this data, if received, was added to the analyses.
Data Extraction and Preparation
All reported neuropsychological data were not reviewed for coding until the final
inclusion/exclusion process had been completed. Once the inclusion/exclusion process had been
completed, neuropsychological data were extracted. Neuropsychological domains were identified
to include attention/concentration, executive functioning, expressive language, IQ, perceptual
reasoning, premorbid IQ estimates, processing speed, psychomotor speed, receptive language,
response speed, sensory/perceptual processing, verbal abstract reasoning, verbal learning and
memory (both contextual and rote), verbal working memory, visual memory, and visual and
spatial working memory. In order to test the first hypothesis as described above, means, standard
deviations, and number of patient and control participants were entered into Biostat’s
Comprehensive Meta Analysis II to perform calculations. Positive direction of an effect size
indicated poorer performance by the mTBI group. Random effects models were employed to be
consistent with previous meta-analysis (Rohling et al., 2011). Both Cohen’s d and Hedges’ g
have been calculated in previous meta-analyses. However, given that Cohen’s d has been
reported to inflate effect sizes when smaller samples are used, Hedges’ g (Hedges & Olkin,
1985) with a bias correction factor was used in the current meta-analysis in order to present a
more conservative estimate. Hedges’ g is a standardized mean difference formula with a
correction factor where f(m) = bias correction factor, nc = number of control subjects, nt =
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number of mTBI subjects, sc = standard deviation of control subjects, and st = standard deviation
of mTBI subjects.
Equation 1
Hedges’ g

Sample demographic and descriptive data were extracted including the study’s country of
origin, setting of the study (e.g., university, hospital), proportion of male and female, age,
handedness, education, litigation status, time post-injury, MTBI definition, and etiology of injury
(see Appendix 1 for an example of the code book). Studies did not consistently report all sample
descriptions (see Tables 3, 4, 5, and 6 below).
Results
Search and rating procedures from January 2003 to August 2010 produced a total of 12
studies (k = 12). Tables 3 through 6 below present demographic and descriptive data for the 12
studies. Seven of those studies were given an AAN ranking of I or II and five were given an
AAN ranking of III or IV (see Tables 7 and 8). In studies ranked I-II, a total of 141 mTBI
participants and 140 control participants were assessed. In studies ranked III-IV, a total of 191
mTBI participants and 121 control participants were assessed. A total of 188 means and standard
deviations were entered for analysis; 102 of which were from the articles with an AAN rating of
I or II and 86 of which were from the articles with an AAN rating of III or IV. When all rated
articles were combined (see Table 9), an overall effect of g = 0.45 was observed. The Classic
Fail-safe analysis indicated that 71 studies reporting null results would be necessary to reduce
this finding to nonsignificance. The Q statistic was not significant indicating a reasonable
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Table 3
Demographic Data for Studies Ranked I and II
Year

Group

N

Sex

Mean Age
(SD/Range)

Handedness

Differences in
Demographics

Blanchet et al.

2009

MTBI
Control

13
12

M/5F
6M/6F

26.31 (5.23)
26 (5.34)

10R/3L
10R/2L

Matched according to age,
gender, handedness, and
education

Ge et al.

2009

MTBI
Control

21
18*

6F/15M
4F/14M

34.1 (8.6/22-54)
36.1 (10.6)

Matched by education,
gender, and age

0.0%

Konrad et al.

2010

MTBI
Control

33
33

16F/17M
16F/17M

36.7 (12.4)
37 (12)

Matched by age, gender, and
education

25.0%

Kraus et al.

2007

MTBI
Control

22
18

9M/13F
7M/11F

35.85 (9.39)
32.83 (10.65)

No significant difference on
estimated premorbid IQ

9.1%
0.0%

Lee et al.

2008

MTBI
Control

28
18

5F/23M
3F/15M

30.3(8.6)
34.3 (8.9)

Matched by gender,
education, handedness, and
age

22.2%

Little et al.

2010

MTBI
Control

12
12

Miles et al.

2008

MTBI
Control

12
29

Author(s)

6F/11M**
14F/15M

27R/0L/1A
16R/2L

31.2 (SEM = 2.71)
30.8 (SEM: 3.04)

Matched by age, education,
and premorbid IQ

33.44 (18-58)
35 (18-61)

Matched by age and gender

%
Attrition

29.00%

*Reported both 18 and 20. **Does not account for attrition of 5 participants whose sexes were not detailed. ***Possible significant differences for gender (Comparison of 5 different groups;
not just mTBI & Control)
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Table 4
Demographic Data for Studies Ranked III and IV

Author(s)
Hattori et al.

Year

Group

N

Sex

Mean Age (SD/Range)

2009

MTBI

15

12M/3F

45 (11/27-60)

Control

15

3M/12F

43 (9/28-58)

Handedness

Non-significant
Differences in
Demographics
No significant
difference on age &
education

Heitger et al.

2006

MTBI
Control

37
37

24M/13F
24M/13F

29.1 (12.7/15-56)
29.2 (12.6/15-57)

Matched by age,
education, gender, and
IQ

Kwok et al.

2008

MTBI
Control

15
19

9M/6F
11M/8F

39.13 (11.46)
44.47 (7.49)

No significant
difference on age,
education, gender, IQ,
or BDI-II

Meyers &
Rohling

2004

MTBI

57**

43M/14F

36.93 (15.1)

51R/6L/0A

Control

30**

15M/15F

38.6 (18.89)

29R/1L/0A

Ord et al.

2009

MTBI

67

42M/25F

38.9 (11.4)

Control

20

16M/4F

33.2 (10.6)

** Number of participants varied between tests administered

No significant
difference on all
demographic data
No significant
difference for age,
education, & ethnicity

%
Attrition
3.33%

51.6%
38.71%
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Table 5
Study Details for Studies Ranked I and II
Author(s)
(year)

Country of
Origin

Site of
Study

Time Post mTBI

Definition of mTBI

Blanchet et al.,
(2009)

Canada

Uni/Hosp

Range = 4-99 months

LOC < 30 min, PTA < 24 hrs, GCS = 1315; transitory neurologic abnormalities;
confusion or disorientation

Ge et al., (2009)

USA

Hosp

Range = 6 months to 7
years

LOC < 30 min, PTA ≤ few hours, GCS ≥ 13

Konrad et al.,
(2010)

Germany

Uni/Hosp

Range = 4.75 – 7.25 years

LOC < 3 0min, PTA < 24 hrs, GCS = 13-15

Lee et al., (2008)

USA

Hosp

1 year

LOC < 30 min, PTA present, GCS = 13-15

Little et al.,
(2010)

USA

Uni/Hosp

>1 year

LOC < 30 min, PTA < 24 hrs

Miles et al.,
(2008)

USA

Hosp

6 months

LOC < 20 min, PTA < 24 hrs, GCS = 13-15

RCI = Residual Cognitive Impairment. Hosp = Hospital. Uni = University.

Definition
of RCI

Symptom Validity

Litigation and
Disability Claim
1 in litigation

Excluded if failed effort
testing

Excluded if failed effort
testing

Excluded if history of
litigation
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Table 6
Study Details for Studies Ranked III and IV
Authors(s)
(year)

Country of
Origin

Site of Study

Time Post
mTBI

Definition of mTBI

Definition
of RCI

Symptom Validity
Measures

Litigation and
Disability Status

Hattori et al.,
(2009)

USA

Uni/Hosp

>6 months

LOC < 30 min, PTA < 24 hrs,
GCS = 13-15

PASAT scores not
different from
controls

6 in litigation

Kwok et al.,
(2008)
Heitger et al.,
(2006)

China

Uni/Hosp

3 months

New
Zealand

Uni/Hosp

6 months*

LOC < 30 min, PTA < 24 hrs,
GCS = 13-15
LOC ≤ 15 min, PTA < 24 hrs,
GCS 13-15, hrs,

Meyers &
Rohling
(2004)
Ord et al.,
(2009)

USA

Uni/Hosp

>6 months

LOC ≤ 20 min

9 effort measures;
could fail only one

0 in litigation

USA

Private
Practice
(records
available)

>1 year

LOC < 30 min, PTA < 24 hrs,
GCS = 13-15; no neurological
signs; no abnormalities on
neuroimaging associated with
head injury

Used at least 2 effort
measures

“most” were
involved in
litigation

0 in litigation

RCI = Residual Cognitive Impairment. Hosp = Hospital. Uni = University. *The six-month data was used in this longitudinal study.
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homogeneity amongst studies. When studies ranked I-II were combined, an overall effect of g =
0.52 was observed. The Classic Fail-safe analysis indicated that 24 studies reporting null results
would be necessary to reduce this finding to nonsignificance. The Q statistic was not significant
indicating a reasonable homogeneity amongst studies. When studies ranked III-IV were
combined, an overall effect of g = 0.38 was observed. The Classic Fail-safe analysis indicated
that 8 studies reporting null results would be necessary to reduce this finding to nonsignificance.
The Q statistics were not significant in all analyses indicating a reasonable homogeneity
amongst studies. Given that the Q statistics were nonsignificant and given the small k in the
study, further moderator analyses were not deemed necessary. Although Q statistics were
calculated and were not significant in all analyses, this does not, however, necessarily indicate
that there is not important variability among effect sizes that may be due to error stemming from
sources other than subject-level sampling error. That is, a nonsignificant Q-value may be due to
the small k and small sample sizes within the included studies (Lipsey & Wilson, 2001).
Additionally, Figure 2 is a funnel plot representing the relative effect size spread for the overall
combined effect for all studies (g = 0.45). (See Appendix 2 for the funnel plots displaying the
effect of studies ranked I or II [g = 0.52] and for the effect of studies ranked III or IV [g = 0.38],
respectively.) Funnel plots are often used as a visual assessment of publication bias (Borenstein
et al., 2009). As Borenstein and colleagues point out, using the standard error on the Y axis is
advantageous for detecting potential publication bias because “smaller studies” (that are less
likely to be published) will tend to have more standard error and will be spread out along the
bottom half of the plot making it easier to visually detect asymmetry in the plot. They further
point out that “In the absence of publication bias, the studies will be distributed symmetrically
about the mean effect size, since the sampling error is random. In the presence of publication

28
bias the studies are expected to follow the model, with symmetry at the top, a few studies
missing in the middle, and more studies missing near the bottom” (emphases in original, p. 283).
As can be seen in the Figure 2, overall there are gaps in the top of the funnel which represents
“large” studies with small standard errors and in the bottom of the funnel which represents
“small” studies with large standard errors indicating potential missing studies in these two areas.
Analyses of effects for neuropsychological domains, which had at least five data points available
for analysis, were also calculated; all of which were significant (see Table 10). In studies rated III, verbal working memory demonstrated the largest effect (g = 0.57), followed by processing
speed (g = 0.56), verbal memory for a list (g = 0.54), attention/concentration (g = 0.48),
executive functioning (g = 0.36), and visual memory (g = 0.33). In studies rated III-IV,
significant effects for neuropsychological domain were observed in expressive language (g =
1.02), followed by attention/concentration (g = 0.64), verbal memory (g = 0.55), perceptual
reasoning (g = 0.52), processing speed (g = 0.33), executive functioning (g = 0.33), visual
memory (g = 0.32), and verbal working memory (g = 0.31).
To test the second hypothesis, an independent t-test was conducted using each study’s
mean effect size (g) and grouped by whether the study received an AAN rating of I-II or III-IV.
In this way, I was able to compare whether significant differences in effect size can be detected
in studies with variable methodological rigor as a function of AAN rating. The t-test was
nonsignificant, t(10) = .636, p = .845. Cohen (1992) points out that, for a significant difference
between means to be observed with a medium effect size (i.e., d = 0.50), power of .80, and α =
0.05, 64 observances in each group would be necessary. It is possible, therefore, that the analysis
was underpowered; the I-II group had only seven mean effect sizes and the III-IV group had only
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Table 7
AAN Criteria for Articles rated I or II

Author (date)
Blanchet et al.
(2009)
Ge et al.
(2009)
Konrad et al.
(2010)
Kraus et al.
(2007)
Lee et al.
(2008)
Little et al.
(2010)
Miles et al.
(2008)

Comparison Study Patient
Reference
Final
Completeness Masking
Group
Design Spectrum Standard
Rating
I

II

I

I

I

II

II

I

II

I

I

I

II

II

I

II

I

I

I

II

II

I

II

I

I

I

II

II

I

I

I

I

I

II

II

I

II

I

I

I

II

II

I

II

I

I

I

II

II

Table 8
AAN Criteria for Articles rated III or IV

Author (date)
Hattori et al.
(2009)
Heitger et al.
(2009)
Kwok et al.
(2008)
Meyers &
Rohling (2004)
Ord et al.
(2008)

Comparison Study Patient Reference
Final
Completeness Masking
Group
Design Spectrum Standard
Rating
I

II

I

I

I

III

III

I

I

I

I

I

III

III

I

I

I

I

I

III

III

I

II

I

II

I

III

III

I

II

I

I

I

III

III
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five mean effect sizes accounting for the total k of 12. It should be noted, however, that the I-II
group did display a larger effect size (g = 0.52) compared to the III-IV group (g = 0.38) and it is
therefore possible that with more observations in each group a significant difference may be
detected.
Table 9
Meta-analytic Data
Study Author(s)

Lower Upper
z
Limit Limit value

p
value

Standard
Error

Variance

0.33
0.97
0.67
0.13
0.33
0.65
0.35
0.35
0.52

0.39
0.33
0.25
0.31
0.12
0.3
0.4
0.34
0.12

0.15
0.11
0.06
0.1
0.02
0.09
0.16
0.12
0.015

-0.44
0.31
0.18
-0.49
0.09
0.05
-0.43
-0.32
0.28

1.09
1.62
1.16
0.75
0.58
1.25
1.14
1.02
0.76

0.83
0.41
2.9 0.001
2.66
0.01
0.42
0.67
2.68 0.007
2.13
0.03
0.88
0.37
1.03
0.3
4.27 0.0001

0.56
0.31
0.29
0.76
0.03
0.38
0.45

0.36
0.23
0.34
0.24
0.25
0.14
0.09

0.13
0.05
0.12
0.06
0.06
0.02
0.01

-0.15
-0.15
-0.38
0.29
-0.47
0.12
0.28

1.27
0.76
0.96
1.22
0.52
0.65
0.62

1.54
0.12
1.33
0.18
0.85
0.39
3.18 0.001
0.1
0.92
2.85 0.004
5.26 0.0001

g

Studies Rated I and II
Blanchet et al.
Ge et al.
Konrad et al.
Kraus et al.
Visual Memory
Lee et al.
Little et al.
Miles et al.
Total
Studies Rated III and IV
Hattori et al.
Heitger et al.
Kwok et al.
Meyers & Rohling
Ord et al.
Total
Overall Total
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Table 10
Meta-analytic Data for Neuropsychological Domain
Domain
Studies Rated I and II
Verbal Working Memory
Processing Speed
Verbal Memory (list)
Attention/Concentration
Executive Functioning
Visual Memory

Variance

Lower
Limit

Upper
Limit

z
value

p
value

0.14
0.13
0.05
0.11
0.11
0.12

0.02
0.02
0.003
0.01
0.01
0.02

0.29
0.3
0.43
0.25
0.14
0.09

0.84
0.82
0.65
0.72
0.59
0.58

4.01
4.21
9.84
4.09
3.21
2.68

0.001
0.001
0.001
0.001
0.001
0.007

0.23
0.09
0.09
0.15
0.11
0.11
0.14
0.1

0.05
0.01
0.01
0.02
0.01
0.01
0.02
0.01

0.57
0.46
0.38
0.22
0.11
0.12
0.04
0.12

1.47
0.83
0.72
0.81
0.56
0.54
0.59
0.5

4.46
6.8
6.41
3.44
2.89
3.09
2.26
3.16

0.001
0.001
0.001
0.001
0.004
0.002
0.024
0.002

g

Standard
Error

0.57
0.56
0.54
0.48
0.36
0.33

1.02
0.64
0.55
0.52
0.33
0.33
0.32
0.31

Studies Rated III and IV
Expressive Language
Attention Concentration
Verbal Memory (list)
Perceptual Reasoning
Processing Speed
Executive Functioning
Visual Memory
Verbal Working Memory

Discussion
Taking the recommendations from Carroll et al. (2004) this updated meta-analysis on the longterm cognitive outcomes following mTBI included studies from January 2003 to August 2010
and sought to increase homogeneity in study inclusion. An established criteria to rate the
methodological rigor of studies was employed (Edlund et al., 2004) to increase homogeneity
within our sample and to limit potential sources of error that can enter into studies with less
rigorous methodologies (Cook & Campbell, 1979). Additionally, to get the most objective sense
of the data, I did not enter zeros into the data set when authors indicated null results for either
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Figure 2
Funnel Plot for all Studies around the Combined Effect
Funnel Plot of StandardError by Hedges's g
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neuropsychological tests or neuropsychological domain and instead attempted to procure data
from authors. Several authors were asked to provide additional data and only two responded.
However, the studies whose authors provided these additional data did not meet final inclusion
criteria and therefore the data was not entered into the current data set.
Search and rating procedures for the time period from 2003 to 2010 produced a total of
12 studies (k = 12) that met inclusion criteria. Seven of those studies were given an AAN ranking
of I or II and five were given an AAN ranking of III or IV. In studies ranked I-II, a total of 141
mTBI participants and 140 control participants were assessed. In studies ranked III-IV, a total of
191 mTBI participants and 121 control participants were assessed. A total of 188 means and
standard deviations were analyzed; 102 of which were from articles with an AAN rating of I or II
and 86 of which were from articles with an AAN rating of III or IV.
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Results from this meta-analysis indicate statistically significant long-term cognitive
effects following mTBI can be observed in studies from January 2003 to August 2010. When all
studies were combined, a significant effect size of g = .45 was shown which represents a small to
moderate effect size based on Cohen’s (1992) guidelines. When studies met criteria for an AAN
rating of I or II, a significant effect for long-term cognitive sequelae following mTBI was
observed (g = 0.52) which represents a moderate effect size based on Cohen’s guidelines. When
studies met criteria for an AAN rating of III or IV, a small but significant effect for long-term
cognitive sequelae following mTBI was observed (g = 0.38). These differences in effect sizes
between studies rated I-II and III-IV, however, were not significantly different when a t-test was
performed. Thus, it is possible that methodological rigor as defined by AAN criteria does not
statistically predict larger effect sizes for studies rated I and II. It is possible, however, that the ttest was underpowered and given the difference in effect sizes between studies rated I and II (g =
0.52) and those rated III and IV (g = 0.38), if more studies meeting our inclusion criteria and
AAN criteria were available, a significant effect may be detected. Cohen (1992) points out that,
for a significant difference between means to be observed with a medium effect size (i.e., d =
.50), power of .80, and α = .05, 64 observances in each group would be necessary. This study
only had seven in one group and five in the other.
In studies rated I-II, significant effects for neuropsychological domain (with at least five
data points available for analysis) were from g = 0.57 for verbal working memory to g = 0.33 for
visual memory (see Table 10 above). In studies rated III-IV, significant effects for
neuropsychological domain (with at least five data points available for analysis) were from g =
1.02 for expressive language to g = 0.31 for verbal working memory (see Table 10 above).
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These results are in contrast to the findings of previous meta-analyses (see Table 11
below). Differences in meta-analytic methodology may account for these differences. First, we
used data from January 2003 to August 2010 to determine if studies in mTBI have demonstrably
improved methodological quality since Carroll et al. (2004) first identified the poor quality of the
mTBI literature. Second, we used AAN’s established criteria for clinical practice guidelines
(Edlund et al., 2004) to determine the methodological quality of a study in order to give us a
reasonable assurance of limited bias and increased heterogeneity within the source studies that
met inclusion criteria. Despite this quality assurance process, or perhaps because of it, we were
able to identify only seven studies that met AAN criteria for a rating of I or II and which also met
our inclusion criteria and only five that met AAN criteria for a rating of III or IV and which also
met our inclusion criteria. Therefore, the paucity of quality research in mTBI up to August 2010
continues particularly as it relates to experimenters being blind to group when administering
neuropsychological assessments. Previous meta-analyses did not use this type of scrupulous
filtering process in the selection of articles that was based on an accepted rating of
methodological rigor and therefore the front-end assurance of homogeneity among included
studies cannot be as easily verified. Lastly, we did not enter zeros into our data set when authors
reported null effects for neuropsychological test or neuropsychological domain as previous metaanalysts have done. We did not enter zeros into our data set because it is difficult to determine
how many zeros should be entered into the data set if information is missing from published
studies. The process of adding zeros in place of missing data then becomes completely subjective
and, if not reported in the meta-analysis, not open to peer review.
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Table 11
Comparison of Effect Sizes Reported by Meta-analysts
Meta-analysis
Binder et al., 1997
Frencham et al., 2005
Rohling et al., 2011
Present Meta-analysis

Effect Size
g = 0.07
g = 0.11
g = -0.07
g = 0.52

Although this study demonstrated some improvements from previous meta-analyses there
are nevertheless limitations to the study. For instance, criteria were used to rate the
methodological rigor of neuropsychological studies that were not specifically developed for
neuropsychology. It is possible that the criteria employed by AAN do not meet the exact needs
of neuropsychology. It is because of this that the criteria in the Cappa et al. (2011) meta-analysis
need to be further developed and honed to the specific needs of neuropsychology. Once this
rating system is in place, authors will have an a priori outline of what is expected in terms of
outstanding methodological rigor and thus additional methodologically sound meta-analyses can
be conducted to further our understanding of the potential long-term sequelae of mTBI.
A second limitation of the current study was related to the AAN criterion assessing
“blinding” or “masking.” According to this criterion, a study component is considered blind if
the assessor is not aware of the participants’ group affiliation. There were no studies that met
inclusion criteria in which an assessor of a neuropsychological test was blind to group affiliation.
Therefore, if any one component of a study in which the authors were blind to group affiliation
(e.g., neuroradiologist was blind to group when rating brain scans) the study was determined to
meet the criteria for being blind. These studies were downgraded to a rating of II instead of I
because the assessor of the primary variable of interest was not blind to group. Additionally,
studies which used computerized testing were determined to meet “masking” criteria for those
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measures given the experimenters less direct influence on the participant and were given a rating
of II. That is, computerized measures have been empirically shown to foster less participant test
anxiety and negative evaluations of the testing condition compared to paper- and-pencil testing
which may influence test performance (Collerton et al., 2007; Fritts & Marszalek, 2010).
It is of note that an extraordinary increase in the amount of mTBI publications has
continued since the cutoff point (i.e., August 2010) of the current study. Recall that my initial
search from January 2003 to August 2010 resulted in 1,631 articles. A cursory PubMed search
dated 04/25/2013, restricted to articles published since August 2010, and with the search terms
“mild traumatic brain injury neuropsychological” yielded 200 articles. Thus, in 32 months’ time,
this amounts to approximately six published studies per month. It is true, however, that not all of
these studies will be experimental (e.g., reviews, case studies, etc.) and not all will be related to
mTBI (e.g., some studies involving stroke or more severe brain injury were also captured in the
search). However, even if 1/3 of these studies were related to the neuropsychological outcomes
following mTBI, this would still yield approximately two published studies per month on the
topic. Although studies confirming (e.g., Dean & Sterr, 2013; Zhou et al., 2013) and
disconfirming (Lange, Iverson, Brubacher, Madler, & Heran, 2012) long-term sequelae of mTBI
continue to be published, I am still unaware of any large scale studies that are prospective,
longitudinal, and utilize an orthopedically injured control group to better understand the potential
long-term effects of mTBI. These types of studies are critical to our understanding of the
potential long-term sequelae of mTBI and are needed for a better meta-analytic understanding of
the long-term sequelae of mTBI.
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Conceptual Critique
Given that the type of studies that are most beneficial for meta-analysis have simply not
been conducted and given that multiple concerns remain in the field of mTBI research, the
following critique is offered in an attempt to further our knowledge regarding mTBI.
Determining Methodological Rigor for Meta-Analyses
As mentioned above, Cappa et al. (2011) showed the importance of establishing
conclusions from meta-analyses involving TBI based on a front-end selection process. The
importance of using a front-end selection process to select studies to include in a meta-analysis is
two-fold: first, to have reasonable assurance of the methodological quality of studies and second,
to establish a reasonable heterogeneity amongst included studies. These authors developed an
excellent system of rating methodological rigor based on a rating scale from “A” to “I” with an
overall rating from zero to nine points. They used this system to determine front-end,
methodologically-based inclusion criteria that increase the likelihood that included studies will
be less influenced by potential bias and increase homogeneity within the studies meeting
inclusion criteria. Although this system has not been established as a gold standard and continues
to be developed, it shows excellent promise for becoming a system by which methodological
rigor can be assessed in studies specific to neuropsychology.
In order to further the development of Cappa and colleagues (2011) rating criteria, I offer
the following suggestions for improvement. For instance, based on criterion A and E, credit
would not be given to cross-sectional studies in which description of participants lost to attrition
would not be reported as it should be in prospective/longitudinal studies. Thus, well designed
cross-sectional studies would be downgraded both for criterion A (not prospective /longitudinal)
and Criterion E (no report of those lost to attrition because they are measured only once).
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Further, these authors indicated that a study would not meet criterion B if the study did not use
multivariate modeling. However, studies using univariate statistical models give useful
information and no explanation is given by Cappa and colleagues why multivariate modeling is
methodologically preferred over univariate. Moreover, the definition of “blinding of assessor” in
criterion I is important, but does not fully capture the idea of an assessor being blind to group. A
more specific definition such as “assessor of neuropsychological functioning was blind to group
affiliation” should be added to criterion I in order to make explicit the need to limit experimenter
influence on test performance. Computerized testing also needs to be addressed in the definition
of blinding and specific recommendations made regarding computerized testing should be
proffered. In reference to criterion H, it appears that Cappa and colleagues had specific reasons
for stating that “The majority of the variables [must be] assessed using standardized measures for
which normative data exists and/or reliability and validity analyses have been conducted” (p.
544, emphasis added). In rating the methodological rigor of an article, it is foreseeable that by
stating all the variables (rather than the “majority”) must be assessed using standardized
measures may unnecessarily lower the rating of some well-designed studies that use
experimental means to measure cognitive performance. However, it should also be noted that,
when meta-analyzing cognitive performance data, experimental test procedures should not be
included quite simply because we do not know the reliability and validity of these measures
(Pertab et al., 2009). Additionally, in order to objectively assess the specific reliability and
validity of a measure, the lower limit acceptable for reliability and validity coefficients (e.g., is it
0.80, 0.90, etc?) should be specified and met in order to receive credit for criterion H. Criterion J
should be added which stipulates that symptom validity measures should be given in order to test
for effort. Although symptom validity testing is still under development and is itself a hotly
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debated topic (Bigler, 2012), given that effort has been shown to significantly impact
neuropsychological test performance, as symptom validity testing continues to improve it will be
important to assess and control for it (An, Zakzanis, & Joordens, 2012; Fox, 2011).
Penultimately, a criterion K can be added delineating definitions for diagnoses used for mTBI
and criteria for residual impairment following an mTBI. When definitional analyses are
available, the variance associated with different definitions can be assessed and the differences
between definitions examined. Lastly, once their criteria for assessing methodological rigor have
been refined, it will be important to conduct studies to determine which criteria account for the
most variance in long-term sequelae after mTBI. In this way, amount of variance accounted for
by criteria can help weight the importance of each criterion and more credence can then be given
to those criteria that account for more variance in outcome.
As this system of rating methodological rigor continues to develop, it will be a much
needed addition to neuropsychological research, to our ability to determine methodological rigor,
and to improve our meta-analytic understanding of the long-term cognitive sequelae of mTBI
and other neuropsychological constructs of interest. Once a rating system has been put in place, I
propose that all neuropsychological studies be rated and ranked according to that standard. This
ranking should become as essential as an abstract. Just as an abstract gives a brief detailing of a
study, a standardized ranking would also give a brief detailing of the methodological rigor of a
study. Thus, consumers of the research can be aware of possible concerns regarding the validity
and potential bias (Cook & Campbell, 1979) associated with each ranking and further critique
studies based on this information. Edlund et al. (2004) state:
An important step in developing a guideline is to measure the risk of bias
in each included study. Bias, or systematic error, is the study’s tendency to
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inaccurately measure the intervention’s effect on the outcome. It is not
possible to directly measure the bias of a study…However, using wellestablished principles of good study design, we can estimate the risk of
bias of a study. (p. 18)
Using a system of rating methodological rigor can inform consumers of potential levels of bias
associated with a given study, thus allowing informed evaluation and decision making regarding
the merits of the inferences and conclusions of the study to improve clinical practice.
The Problem of mTBI Definition
As indicated above, definitional problems of mTBI have long been disputed (Bigler,
2008; Carroll et al., 2004; Ruff et al., 2009). These problems stem in large part due to the means
of assessing mTBI. Currently, it is largely accepted that to diagnose mTBI it must be as a result
of external force or rapid acceleration/deceleration forces that disrupt brain function and that
three criteria, based on three means of behavioral assessment, are needed in order to diagnose
mTBI following the trauma. These criteria include: Glasgow Coma Scale (GCS) from 13 to 15,
loss of consciousness (LOC) for less than 30 minutes, and post traumatic amnesia (PTA) of less
than 24 hours. However, qualifiers such as “focal neurological signs,” “altered consciousness,”
or “period of confusion” are often added and definitionally sufficient for diagnosing a
concussion (American Congress of Rehabilitation Medicine Head Injury Interdisciplinary
Special Interest Group, 1993; Carroll et al., 2004).
These criteria are problematic because they are often associated with measurement error.
For example, GCS is often not assessed within a reasonable timeframe to determine severity of
injury (e.g., not assessed at time of injury or shortly thereafter) and sometimes it is not assessed
at all. Additionally, although some have suggested that GCS should be measured approximately
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30 minutes following a concussion (American Congress of Rehabilitation Medicine, 1993;
Carroll et al., 2004), there is no agreed upon, empirically based timeframe during which GCS
should be assessed in order to understand the severity of the head injury. Although Carroll and
colleagues are well intended in their attempt to address this concern, there is still left an
extremely large margin of potential error when GCS is measured. These authors state:
We agree with the American Congress of Rehabilitation Medicine definition,
which specifies that the GCS score of 13–15 be assessed after 30 minutes
post-injury. However, we recognize the practical concern that individuals
with MTBI will rarely be assessed at an emergency department within this
time frame. Therefore, although an assessment of GCS score just after 30
minutes post-injury remains the ideal, our proposed definition permits
diagnostic use of a GCS score assessed by a qualified healthcare provider at
the first opportunity. (p. 115)
Although their definition allows for diagnostic use of GCS score “at the first
opportunity,” there is no telling when this first opportunity may occur, if at all. Thus, the
question then becomes does an individual who has a GCS of 13 at 30 minutes post injury have
the same level of injury as an individual with a GCS of 13 at 120 minutes post injury? Or 240
minutes post injury?
LOC and PTA have similar problems with being assessed and measured. LOC, for
instance, is usually assessed by asking the patient if he/she lost consciousness after the accident.
However, patients who have been acutely concussed (or those trying to recall the details of their
accident days or weeks after the injury occurred) are typically unable to accurately self-report
(Ruff et al., 2009). Additionally, if an individual loses consciousness, it is difficult for them to
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accurately gauge how long the period of unconsciousness actually lasted. It is similarly difficult
for them to tease apart LOC from PTA. The question is often, “Did I lose consciousness or do I
simply not recall what happened?” It is clearly better to have collateral data from an outside
observer reporting on whether an individual was unconscious and, if so, for how long. However,
this is also problematic as the outside observers rarely actually time the duration of the LOC and
therefore rely on memory and approximations to gauge the length of LOC if present. Moreover,
is an LOC of 30 seconds equivalent to the level of neurologic injury as an LOC of 30 minutes?
Should these times of LOC be equated in a definition of mTBI? Although attempts to alleviate
this problem have been made by using “grades” of mTBI based on more specific criteria
(American Academy of Neurology, 1997; Leclerc, Lassonde, Delaney, Lacroix, & Johnston,
2001), grading of mTBI still suffers from the same problems of assessment and measurement
that are associated with assessing GCS, LOC, and PTA as outlined here.
Assessing PTA is similarly problematic in that many individuals have been told about
what happened at the time of their accident several times which can cause a memory trace, albeit
an often false (or at least biased) memory trace, that is often difficult to distinguish from what the
individual actually recalls from the accident. As Ruff and colleagues (2009) point out, “it is
essential to determine what the patient remembers versus what he or she has been told or has
surmised” (p. 6). These authors further point out that assessing PTA can be problematic due to
intoxication, psychiatric concerns (e.g., acute stress disorder, post-traumatic stress disorder), or
psychogenic amnesia caused by significant emotional trauma. Thus, individuals are often left
piecing together and making sense of the experience based on their own recollections, what
others have told them, and those details that are simply lost in the complexity of the process.
This confusion between actual memory and a memory trace that was created by hearing the story
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of the accident (with relevant details possibly missing) makes assessing PTA quite problematic.
Moreover, there is evidence that PTA and LOC are not necessarily part of the sine qua non of
mTBI (Smits et al., 2007). Smits and colleagues (2007) showed that those with mTBI may or
may not demonstrate LOC and PTA. These authors point out, for example, that of their 2,462
study participants who consecutively presented to the emergency department those individuals in
their study who had mTBI and who required neurosurgical intervention did not significantly
depend on whether PTA and LOC were present (six patients with PTA and LOC versus four
patients with no PTA and LOC). Interestingly, although all participants in the study met criteria
for mTBI on behavioral observation (e.g., GCS, PTA, LOC) these 10 patients nevertheless
displayed indications for neurosurgery which included “isolated depressed skull fracture (n=1),
epidural haematoma (n=4), subdural haematoma (n=4) and a combination of epidural and
subdural haematoma (n=1)” (p. 1,362).
Given these problems, researchers are trying to determine more objective, biological
markers to define and diagnose mTBI. Brain imaging has been a focus of identifying biological
markers for psychiatric concerns for many years (Farah & Gilihan, 2012). These methods are
also being used to identify biological markers of brain injury that potentially will aid with the
definitional problems discussed above and lead to better prediction of outcome and treatment
options (Bigler & Bazarian, 2010; Mayer et al., 2010).
Although this literature is too large to fully review here, a few instances will illustrate the
point. For example, Huang and colleagues (2009) point out that mTBI can often be difficult to
objectively diagnose given lack of external injuries and because neurological damage if present
is often not detected on conventional acute MRI or CT. Given the capability of MEG to detect
the low-frequency neuronal magnetic signal generated following TBI and the capability of DTI
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to identify abnormalities of white matter tracts, Huang and colleagues (2009) integrated the two
imaging modalities to determine whether these technologies would be more sensitive in detecting
subtle neuronal injury in mTBI than conventional neuroimaging. These researchers’ data showed
four relevant findings: 1) MEG and DTI combined are more sensitive than conventional MRI
and CT to detect neuronal damage in mTBI, 2) MEG slow waves tended to originate from
cortical gray matter areas that experienced de-afferentation from axonal damage to white matter
tracts, 3) post-concussive symptoms are consistent with MEG and DTI findings, and 4) in some
cases where DTI did not show abnormalities in white matter MEG was still able to detect
abnormal neurological signals.
Chen and colleagues (2003) offer another example of an advanced imaging technology
which detected neurological changes and subsequent neuropsychological deficits associated with
mTBI. These researchers used PET to compare a group of mTBI patients to a group of controls
during resting state and during a spatial working memory task. Findings indicated that no
differences were found between groups in resting state fluro-2-deoxy-D-glucose (FDG) uptake in
frontal and temporal regions of interest. However, differences were identified during the spatial
working memory task with patients displaying smaller increases in regional cerebral blood flow
(rCBF) in right prefrontal cortex compared to controls. Chen and colleagues indicate that their
findings suggest that a cognitive challenge may be necessary to identify neurological changes
associated with mTBI that are not detectable with conventional neuroimaging or on advanced
imaging techniques during resting states.
In summary, as brain imaging modalities such as MEG, SPECT, PET, DTI, SWI continue
to improve, they will become more useful in determining structural and functional neurological
changes and will likely help alleviate not only definitional problems associated with mTBI but
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also help determine neurologically based prognostic indicators and treatment foci (Huang et al.,
2009; Mayer et al., 2010; Niogi & Mukherjee, 2010; Niogi et al., 2008; Shenton et al., 2012;
Toledo et al., 2012; Zhang et al., 2006). In this way, mTBI diagnosis can be based on
radiographic substantiation rather than by symptoms alone that are often self-report and often
unreliable in nature.
Along with neuroimaging techniques, neuro-metabolic changes have also been studied as
biomarkers that have potential to further our understanding of brain pathology following mTBI
(McCrea, 2008). Indeed, lumbar puncture and peripheral blood based measurements of metabolic
processes following brain injury such as neurofilament light protein, glial fibrillary acidic
protein, phosphorylated tau, S100 proteins, neuron specific enolase, and β-amyloid protein may
continue to show reliable and valid neurologic changes that can be used to define head injury
severity and which may correlate with neuropsychological performance (de Kruijk, et al., 2002;
Nygren de Boussard, et al., 2004).
Again, this literature is becoming quite large and I’m not able to fully review it here.
Nevertheless, an example will illustrate the potential of these methods in helping understand
definitional, prognostic, and treatment factors associated with mTBI. de Kruijk and colleagues
(2002) conducted a prospective study of 79 patients seen in the emergency department (ED) less
than six hours after injury and seen again six months later for follow up. Findings indicated that
of the 79 patients 22 (28%) reported one or more post-traumatic complaints at the six-month
follow up. In these patients, a twofold increase in severity of cognitive and vegetative complaints
at six-month follow up was associated with increased blood concentrations of the biochemical
serum markers S-100B and neuron specific enolase at first presentation to the ED. These
researchers found that headache, dizziness, and nausea at initial ED visit were strongly
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associated with the severity of post-traumatic complaints at six-month follow up. Results further
indicated that those with normal serum markers and no neurobehavioral symptoms upon arrival
at the ED recovered fully (n = 10) indicating that those who recover fully and those who don’t
can be better predicted based on these serum markers.
As measurement of neuro-metabolic change continues to develop, we will likely be in a
better position to help us understand the nuances of the potential neurobehavioral impairments
associated with mTBI and help re-define our understanding of mTBI. Indeed, lumbar puncture to
identify potential metabolic processes following TBI is still recommended in the emergency
department alongside CT scans when ruling out hemorrhagic injury following stroke or head
injury when headache, neck pain, or LOC are present (Mark et al., in press) simply because CT
scans do not reveal approximately 20% of hemorrhagic injuries.
In conclusion, the concern about definitional issues is so pressing that Cassidy and
colleagues (2004) state:
There is an urgent need for workable clinical and surveillance definitions of
MTBI and subsequent studies to validate various methods of capturing cases.
Until there is some consistency of definitions and appropriate validation of them,
studies of the incidence of MTBI will remain so heterogeneous that we will be
unable to compare the incidence rates. (p. 2004)
However, since 2004 when Cassidy and colleagues made this statement, little progress
has been made in demonstrating a reliable and valid definition of mTBI. Thus, we are no
closer to being able to compare incidence rates or capture cases. Advanced technologies
such as imaging and serum biomarkers may help elucidate the elusive definition of
mTBI. Once biomarkers are identified, correlations to neurocognitive and
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neurobehavioral sequelae can then be better understood and teased apart from potential
non-neurological causes of decreased cognitive performance (e.g., effort, psychological
concerns, sleep deficiencies, etc.).
The Problem of Residual Cognitive Impairment Definition
In their recent meta-analysis, Rohling et al. (2011) stated that it remains possible but
unlikely that a small number of individuals may continue to experience long-term cognitive
sequelae following mTBI. Theses authors correctly point out that other factors such as poor
effort, premorbid conditions (such as attention deficit/hyperactivity disorder or learning
disorders), pain, or fatigue need to be ruled out before determining whether cognitive deficits are
associated with the mTBI. However, in order to determine whether long-term cognitive deficits
are associated with mTBI, there needs to be an accepted definition of residual cognitive
impairment following mTBI.
Few efforts have been made to determine reliable and valid criteria against which
residual impairment can be weighed. For example, in addition to Iverson and Brooks’ (2011)
work on defining residual cognitive impairment using the Neuropsychological Assessment
Battery (NAB), there have been only two other primary attempts to define residual cognitive
impairment following acquired brain injury (e.g., Reitan and Wolfson’s work on the Halstead
Reitan Neuropsychological Battery [1985, 1993], and Golden and colleagues’ work on the LuriaNebraska Neuropsychological Battery [1985, 2000]. Unfortunately, these three definitions of
cognitive impairment have relied on “fixed” batteries of neuropsychological assessment which
have fallen out of favor in more recent years for “flexible” batteries making the definitions by the
above mentioned researchers less user friendly to today’s neuropsychologist. Iverson and Brooks
(2011) correctly point out a couple of points that bear mentioning here. First, they correctly state
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that there is no agreed upon definition of cognitive impairment that is based on sound statistical
parameters stating that even their own proposed criteria need additional research to refine the
criteria. Second, they point out that there is no accepted and empirically-validated psychometric
criteria for identifying cognitive disorders most likely due to the fact that there is no agreement
on the definition of a “low score” (i.e., 1SD, 2SD) that would help determine whether an
individual experiences a cognitive disorder. These two points (among others) are then left
entirely up to the individual neuropsychologist to resolve on a patient to patient basis.
Given the heterogeneity in causes of mTBI (car accident vs. fall), heterogeneity in
biomechanical forces involved (rotational force vs. translational force), and the heterogeneity in
individual premorbid variability/differences (gender, age, intelligence, education, ethnicity), how
can we determine what residual impairment is for a group of individuals in a research study
(when these variables for the most part are not being considered) let alone for the individual who
is in our office being assessed? What about clinical significance as opposed to statistical
significance (Jacobson & Truax, 1991)? Is a standard score of 95 on a measure of intelligence
indicative of impairment relative to a normative group? What about relative to the patient’s
premorbid level of functioning, let’s say, if his premorbid intellectual functioning was measured
at 120? Can an “average” score be an impaired score for an individual who was once able to fly
jet aircraft in combat and who previously scored in the superior range? It is true, that perhaps an
individual like this may be the most highly functioning individual in his new office job, but
he/she was once a fighter pilot.
Moreover, interindividual variability is ostensibly accounted for by normative data when
appropriate norms are used. But intraindividual variability (Binder & Binder, 2011; Iverson &
Brooks, 2011) remains unaccounted for and needs to be addressed in a definition of residual
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cognitive impairment. That is, because variability exists in any given individual’s
neuropsychological tests results (Binder & Binder, 2011; Iverson & Brooks, 2011), a definition
of what is considered normal and aberrant variability within that individual’s neuropsychological
test results needs to be considered when defining residual cognitive impairment (Iverson &
Brooks, 2011). Because there is no accepted definition of residual cognitive impairment
following mTBI, one cannot objectively state whether the individual continues to experience
cognitive impairment relative to the patient his/herself, and, in a clinical setting the decision is
left to the assessing provider to make that subjective determination without a definition and
empirically-based guideline.
Interestingly, researchers (as opposed to clinicians) implicitly use statistically significant
differences between groups as an ostensible analogue for a definition of residual cognitive
impairment. That is, when a statistically significant difference between an mTBI patient group
and a control group is observed, that statistical difference is implied to mean that there is
“residual impairment” in the mTBI group in that domain of cognitive functioning. But how do
we know there is residual impairment? It is possible that other factors may account for the
statistical difference observed especially when we don’t even know what we mean when we say
“residual impairment” and when most studies don’t take into consideration variables such as
gender, intellectual abilities, ethnicity, education, cognitive reserve, biomechanical forces, etc.
(Bigler, 2008; Farias et al., 2012; Iverson & Brooks, 2011; Pertab et al., 2009). What exactly do
researchers want to imply when statistically significant differences are observed in the patient
group? Do they actually mean to imply that the mTBI group displayed residual cognitive
impairment(s)?
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Additionally, traditional pencil-and-paper neuropsychological tests have been criticized
as possibly not being sensitive enough to detect the changes associated with mTBI in order to
detect residual impairment (Bigler, 2008; Bigler &Bazarian, 2010; Collie et al., 2006; Mayer et
al., 2010). Thus, more sophisticated means of testing should continue to be developed.
Computerized assessment is becoming more automated and more available and has been used
quite extensively now in the assessment of sports-related brain injuries (Cernich, Reeves, Sun,
Bleiberg, 2007; Iverson, Lovell, & Collins, 2005; Leclerc et al., 2001). Computerized testing
using cognitive neuroscience measures has been and continues to be configured to be compatible
with brain imaging techniques thereby increasing the sensitivity to neurologic dysfunction
(Chen, Johnston, Collie, McCrory, & Ptito, 2007; Mayer, Mannell, Ling, Gasparovic, & Yeo,
2011; Mayer et al., 2012; Scheibel et al., 2007). As cognitive neuroscience measures of brain
function become standardized and norms created, we will be better able to detect neurologic
changes that occur on the scale of milliseconds thereby making these measures more sensitive
than traditional pencil-and-paper neuropsychological tests which typically measure on the scales
of minutes and seconds. As these measures become more accurate in describing potential
neurocognitive dysfunction following mTBI, they can also be a tool used to help us refine our
definition of residual impairment.
The Problem of PCS and PPCS
The term post-concussion syndrome (PCS) has been used to describe the complex,
controversial cluster of physical, cognitive, behavioral, and emotional symptoms that may occur
in association with mTBI, and the term persistent post concussion symptoms (PPCS) has been
used when these symptoms continue post three months (Arciniegas, Anderson, Topkoff, &
McAllister, 2005; Bigler, 2008; Hall, Hall, & Chapman, 2005; Satz et al., 1999). PCS and PPCS
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symptoms often include headache, fatigue, insomnia, dizziness, concentration/attention
difficulties, memory loss, irritability, sensitivity to sensory stimuli, and emotional
instability/dysregulation (Bazarian et al., 1999; Bigler, 2008; Ryan & Warden, 2003; Satz et al.,
1999).
PCS symptoms have been criticized as being nonspecific to mTBI patients and have thus
been viewed as having little to no value when ruling in/out mTBI as the cause of these symptoms
(Lees-Haley, Fox, & Courtney, 2001; Silva, Donnell, Kim, & Vanderploeg, 2012). Although it
is true that many PCS symptoms overlap with and could be accounted for by other concerns
(e.g., psychological factors, medication, medical problems, premorbid psychiatric history, etc),
that PCS and PPCS still have definitional problems, and are in fact considered works in progress
(Hall, Hall, & Chapman, 2006; Smith, 2006), it does not necessarily stand that these symptoms
could not be accounted for neurologically in some individuals and therefore related to mTBI
(Shenton et al., 2012).
Related to the above discussion regarding definitional problems, the potential for
advanced neuroimaging techniques to further our understanding of the neurological involvement
in PCS and PPCS is also quite possible. Shenton and coworkers (2012) conducted a thorough
review of the MRI and DTI literature involving mTBI and found overwhelming evidence in the
43 DTI/mTBI studies they reviewed in favor of DTI being able to detect white matter
abnormalities in mTBI above conventional neuroimaging. They state:
Given the different magnet strengths, with some [studies] conducted on a 1.5 T
magnet, and others conducted on a 3 T magnet…, as well as differences in the
analysis methods employed, and the dependent measures used, as well as
differences in the selection of brain regions to investigate, in addition to
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differences in the post-injury time of the study, and differences in whether
subjects had positive or negative findings on conventional CT or MRI, it is
surprising that there is as much convergence and consistency with respect to the
detection of brain abnormalities in mTBI using DTI. (p. 180)
Shenton and colleagues (2012) go on to point out that, despite the various regions of
interest studied using DTI, the corpus callosum was consistently determined to be particularly
susceptible to injury in mTBI as identified on DTI. However, in patients who recover fully from
the concussion injury, there is evidence that a healing process which reverses corpus callosum
damage may occur and that more severe corpus callosum damage without this healing process
may be associated with poorer long-term outcome (Rutgers et al., 2008). It is therefore possible
that these more severe neurological changes and lack of healing process are a part of the causal
factors associated with PCS and which may lead to PPCS.
Despite the difficulties conventional imaging modalities have in detecting neurologic
abnormalities, Arciniegas and colleagues (2005), after conducting a review of the literature
stated that “biomechanical and cytotoxic consequenses of mild TBI [such as calcium and
magnesium regulation, free radical formation, neurotransmitter excitotoxicity, inflammatory
responses, disruption of vascular homeostasis]may be substantial despite an ostensibly ‘mild’
mechanism of injury” (p. 313). It is precisely these biomechanical and cytotoxic consequences
that advanced imaging technologies are becoming more sensative to detect and it is possibly
these very processes that may lead to long-term complications for some individuals following
mTBI. As advanced technologies continue to be developed, our understanding of the
neurological sequealae associated with mTBI will be further elucidated and therefore the
etiology of symptoms whether they be psychogenic, neurogenic, or otherwise will be more
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distinguishable. Being able to differentiate between the various etiologies of PCS-like symptoms
is important for clinicians to correctly diagnose in order to prescribe appropriate treatment and
lead to better outcomes (Potter & Brown, 2012; Ruff, 2005).
The Problem of Heterogeneous Outcome Measurement
Researchers have long lamented the difficulty of fully integrating and understanding the
heterogeneity of outcome data in TBI research (Nightingale, Soo, & Tate, 2007; Willemse-van
Son, Ribbers, Verhagen, & Stam, 2007).The need for a homogeneous system of outcome
measurement can also be seen in recent meta-analytic techniques. Cappa and colleagues (2011)
very nicely demonstrated the problem with the heterogeneity of outcome measurement in
neuropsychology. Although these researchers did not focus solely on mTBI, they nevertheless
found a significant Q statistic for neuropsychological outcome measures and found that that
outcome measure was a significant moderator of the TBI severity and outcome relationship. That
is, the link between injury severity and outcome varied based on the neuropsychological outcome
measure that was used. Cappa and coworkers point out that this level of heterogeneity in
outcome measure makes an integrated understanding of the long-term sequelae of TBI difficult.
In response to these laments, Wilde and colleagues (2010), who are a part of the
interdisciplinary Common Data Elements (CDE) workgroup for common outcome measures in
TBI research, developed a 3-tier system to give guidance to researchers, agencies, and other
populations to facilitate the adaption of a common set of outcome measures to better understand
the effects of all severity ranges of TBI (Nightingale, Soo, & Tate, 2007; Thurmond et al., 2010;
Willemse-van Son, Ribbers, Verhagen, & Stam, 2007). The 3-tier system Wilde and coworkers
(2010) developed consisted of core (tier-one), supplemental (tier-two), and emerging (tier-three)
measures. Firstly, these researchers identified 12 outcome domains which are relevant to
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understanding brain injury. They then identified six criteria by which they would evaluate an
outcome measure’s utility of assessing these domains. Finally, they identified nine tier-one core
measures, twenty tier-two supplemental measures, and nine tier-three emerging measures. Wilde
and colleagues describe the rational for the 3-tier system and state:
In the first tier, core measures included valid, robust, and widely applicable
outcome measures with proven utility in TBI from each identified domain,
including global level of function, neuropsychological impairment, psychological
status, TBI-related symptoms, executive functions, cognitive and physical activity
limitations, social role participation, and perceived health-related quality of life.
In the second tier, supplemental measures were recommended for consideration in
TBI research focusing on specific topics or populations. In the third tier, emerging
measures included important instruments currently under development, in the
process of validation, or nearing the point of published findings that have
significant potential to be superior to some older (“legacy”) measures in the core
and supplemental lists and may eventually replace them as evidence for their
utility emerges. (p. 1650)
Once this type of system is adopted, a better homogeneity amongst outcome measures
used in research will be achieved and less confusion will be had regarding the integration of
heterogeneous measurement. This is important because having a system that guides research
based on accepted outcome measurement will influence researchers to begin using the system
and will then allow for a better, more fully integrated understanding of the long-term cognitive
sequelae of TBI in general and mTBI specifically.
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The Problem of Unaccounted for Variables
In order to better understand the nuances in mTBI, it is important that careful analysis of
all potentially influential variables be conducted. For example, mechanism of injury has been
viewed as an important variable because it may be associated with different neuropsychological
profiles and outcomes. Bigler (2008) points out that a fall injury with translational forces may be
associated with different levels of neurological impairment when compared with an injury
sustained in a motor vehicle accident (MVA) with rotational forces. Moreover, Bigler (2008)
further indicated that various types of MVA may also be associated with various levels of
neurological impairment depending on whether the vehicle rolled, spun, and whether it was hit
from behind, from the side, or from the rear. Each of these aspects associated with the wide
spectrum of mechanisms of injury needs to be carefully addressed in the literature. Additionally,
demographic information such as sex, age, premorbid intellectual functioning, handedness,
education, and family history of neurological and/or psychiatric concerns etc. also need to be
carefully studied (Iverson & Brooks, 2011).
In the current meta-analysis, 11 of 12 source studies reported the sex of participants, 11
of 12 source studies reported information on the age of participants, 3 of 12 source studies
reported on handedness, 10 of 12 source studies reported on education, 2 of 12 source studies
reported on ethnicity, and 7 of 12 source studies reported on psychiatric comorbidity of the
samples used. Variables of particular interest that need to be accounted for in research studies
because of their known influence on neuropsychological performance at a bare minimum include
sex, ethnicity, education, and intellectual functioning (Iverson & Brooks, 2011). Interestingly,
the nuances associated with many other aspects of assessing cognitive functioning can be further
seen in a recent study by Karremans and colleagues (2009). These researchers tested men and
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women who interacted with both female and male research assistants (RA). They found that
when men interacted with female RAs their cognitive functioning was “impaired” when
compared with when they interacted with male RAs. Thus, it is clear that there are many
variables that potentially effect neuropsychological outcome and they must be accounted for in
order for us to fully appreciate, understand, and diagnose mTBI.
Conclusion
Given that the literature up to 2002 has been viewed as lacking in methodological rigor
(Carrol et al., 2004), we sought to further assess the state of the literature from January 2003 to
August 2010 by using the AAN clinical practice guidelines to rank studies published during this
time frame. Only seven studies were identified that met criteria to be given an AAN rating of I or
II and five studies were found that met criteria for an AAN rating of III or IV. This small k is
consistent with the view that methodological rigor continues to be a problem in research on
mTBI, and is further evidence that there continues to be a dearth of research from January 2003
to August 2010 that utilized a high standard of methodological rigor to understand the long-term
sequelae of mTBI. Improved methodological rigor is important as we continue to build our
understanding of mTBI and seek to reduce error associated with less rigorous research designs.
Additionally, this study further emphasizes the potential influence that heterogeneity
amongst studies included in meta-analyses may have on meta-analytic findings. This study
represents the usage of the most rigorous and homogeneous inclusion criteria when compared to
previous meta-analyses on mTBI to date. The larger effect sizes found in the current metaanalysis (i.e., g = 0.52 for studies rated I or II, g = 0.38 for studies rated III or IV, and an overall
combined effect size of g = 0.45) when compared to the smaller effect sizes found in previous
meta-analyses indicate that, as Konrad and colleagues (2010) stated, the debate about long-term
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cognitive sequelae following mTBI remains unresolved. The problem of heterogeneity amongst
included studies and the within study heterogeneity as described above are likely important
variables that need to be considered in future studies.
Moreover, problems associated with using meta-analysis to justify the claim that no
individuals who experience mTBI were addressed (e.g., definitional problems, measurement
problems, etc.). Iverson (2010) has stated that, “…clinicians should not use the results of metaanalysis to state, unequivocally, that MTBI cannot cause residual cognitive difficulties in
individual patients. This is simply an over-generalization and is invariably inaccurate at some
point or other” (emphasis in original, p. 1252). Clearly concerns still exist in various aspects of
research on mTBI. Definitional standards of mTBI and residual impairment of mTBI should be
addressed in order to facilitate better understanding of the phenomenon and epidemiology of
mTBI. Better, more consistently used instruments in evaluating cognitive functioning after mTBI
should also continue to be pursued. Of particular interest are neuroimaging techniques, other
potential biomarkers, and computerized assessment in future studies of mTBI.
As this work continues, it is likely that using more advanced technologies including more
sophisticated means of measuring neuropsychological ability will help us define and correctly
identify neurologic involvement, residual impairments, and inform treatment of symptoms
associated with mTBI. Indeed, President Barak Obama recognizes the need for advancements in
advanced brain-based technologies to better understand brain-behavior relationships (The White
House: Office of the Press Secretary, 2013). President Barak Obama recently unveiled the Brain
Research through Advancing Innovative Neurotechnologies (BRAIN) initiative that will allocate
100 million dollars in research support to,
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“…accelerate the development and application of new technologies that will
enable researchers to produce dynamic pictures of the brain that show how
individual brain cells and complex neural circuits interact at the speed of
thought. These technologies will open new doors to explore how the brain
records, processes, uses, stores, and retrieves vast quantities of information, and
shed light on the complex links between brain function and behavior.”
After all, our ultimate concern as mental health professionals when assessing mTBI
should be to use clinical history, appropriate assessment measures, and informed clinical
judgment to diagnose and inspire empirically validated treatments which improve the well being
and quality of life of our patients. This is the explicit goal of the BRAIN initiative as it “…aims
to help researchers find new ways to treat, cure, and even prevent brain disorders, such as
Alzheimer’s disease, epilepsy, and traumatic brain injury.”
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Appendix 1
mTBI Meta-Analysis Code Book
General Instructions
1. Note that each code below is numbered. When coding, please highlight empirical evidence in
support of the code in the study report, and mark it with the coding reference number.
2. You should indicate a code when plausible. However, if insufficient evidence exists in the
study report to make a plausible coding, then fill in the coding blanks with "-.99" to indicate
unknown.
Code #

Code Description

1

Study Identification Number:

2

Title:

3

Authors:

4

Country:
Site:

1.
2.
3.
4.
5

University
Hospital
Private Clinic
Other

Year of Study:
Study Design:

6

1. Quasi experimental
a. Prospective
b. Retrospective
c. Crossectional

7

Patient N:

8

Patient sex ratio:

9

Patient age (M, SD, range):
Patient Handedness:

10

1. R
2. L
3. A
Patient Marital status:

11

1. Single
2. Married

Code
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3. Divorced
12

Patient SES:

13

Patient Education (M, SD, Range):

14

% patient attrition:

15

Control N:

16

Control sex ratio:

17

Control age (M, SD, range):
Control Handedness:

18

4. R
5. L
6. A
Control Marital status:

19

4. Single
5. Married
6. Divorced

20

Control SES:

21

Control Education (M, SD, Range):

22

% control attrition:
Domain Assessed:

23

1.
2.
3.
4.
5.

Attention/concentration/working memory
Processing speed
Expressive language
Receptive language
Verbal memory

6. Visuospatial ability
7. Perceptual reasoning
8. Visuospatial memory
9. Executive functioning
24

Time post TBI (M, SD, range):

25

1. Definition of MTBI:
a. LOC
b. PTA
c. GCS
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d. Other
Etiology:

26

1. Sports
2. MVA
3. Fall/blow to head
4. Assault

27

Minority Proportion in Sample (For this study minority
is defined as someone belonging to a non-Caucasian
group)
Note: This number should be a decimal (two places) of total
sample

28

Illegal substance use:

29

Psychiatric comorbidity

30

Prior head trauma:
Litigation:

31

1. Yes
2. No
Comparison Type:

32

1. Healthy control
2. Orthopedic injury
3. Other

33

Measures used:

34

Patient mean, SD, Stat test value (e.g., F-test value), p
value

35

Control mean, SD, Stat test value (e.g., F-test value), p
value
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Appendix 2
Funnel Plot for Studies Rated I and II
Funnel Plot of StandardError by Hedges's g
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Funnel Plot for Studies Rated III and IV
Funnel Plot of StandardError by Hedges's g
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